Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-15

Clinical Trial Update: Tranexamic Acid for Craniofacial Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of tranexamic acid for craniofacial surgery in craniosynostosis has been terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Pittsburgh | Conditions: Craniosynostosis, Bleeding | Phase 4 | Status: TERMINATED | Results posted: 2017-02-15